Referenslitteratur för:

Cimicifuga racemosa, Silverax och Remifemin (Ref 1 - 45, A - H)
 
  FÖRFATTARE OCH TIDSKRIFT
PUBLICERAD
HÄMTA PDF
 

1. Aksel S:
Vasomotor symptoms, serum estrogens and gonadotropin levels in surgical menopause.
Am J Obst Gyn 126:165-9, 1976
1976
  
  2. Beral V, Bull D, Doll R, et al.
Breast cancer and hormone replacement therapy: collaborative reanalysis of data
from 51 epidemiological studies of 52705 women with breast cancer and 108411
women without breast cancer.
Lancet 350:1047–59, 1997.

 1997  
  3. Beuscher N:
Cimicifuga racemosa L. – Die Traubensilberkerze (Black Cohosh).
Z Phytoterapie 16:301–10; 1995
1995
  
  4. Bhavani B:
Womens Health Initiative study.
J Obstet Gynaecol Can 24: 689–90, 2002.

 2002  
  5. Blaschek W, Hänsel R, Keller K, Reichling J, Rimper H, Schneider G, Eds.
Hagers Handbuch der Pharmazeutischen Praxis. 2. Erg. Band.
Springer Verlag, Berlin, pp. 347–81, 1998.

 1998
  
  6. Blumenthal M, Hall T, Goldberg A, Kunz T Dinda K. Eds.
The ABC Clinical Guide to Herbs .
American Botanical Council, Austin, Texas, 2003, pp. 13–22.

1998
  
  7. Boblitz N, Liske E, Wüstenberg P:
Traubensilerkerze – Wirksamkeit, Wirkung und Sicherheit von Cimicifuga Racemosa
in der Gynäkologie.
Deutsche Apotheker Zeitung 140: 107–14, 2000.

 2000  
  8. Boblitz N, Nisslein T, Bodinet C, et al.:
Black Cohosh for treatment of climacteric complaints: efficacy, safety and
mode of action.
Prodeedings Book: Recent Research in Gynecological Endocrinology, The Parthenon Publishing Group, New York & London, 2001.

 2001  
  9. Boblitz N:
Levels of Evidence: Black Cohosh.
6th International ESCOP Symposium, Bonn, May 10–11, 2001.

 2001  
  10. Boblitz N:
Therapie klimakterischer Beschwerden mit Cimicifuga racemosa – Erfahrungen in der hausärztlichen Praxis.
Journal für Menopause, Sonderheft 1: 14, 2001.

 2001  
  11. Bodinet C:
Influence of Cimicifuga Extract on the Proliferation of Estrogen Receptor- Positive
Human Breast Cancer Cells.
Schaper & Brümmer 1996.

 1996  
  12. Bodinet C, Freundenstein J:
Influence of Cimicifuga racemosa on the proliferation of estrogen receptor-positive human breast cancer cells.
Breast Cancer Res Treat 76: 1-10, 2002.

 2002 Hämta här
  13. Bolle P, Mastrangelo S, Perrone F, Evandri MG:
Estrogen-like effect of a Cimicifuga racemosa extract sub-fraction as assessed by
in vivo, ex vivo and in vitro assays.
J Steroid Biochem Mol Biol: 2007, in press

 2007
 Hämta här
  14. Borrelli F, Ernst E.
Cimicifuga racemosa: a systematic review of its clinical efficacy.
Eur J Clin Pharmacol 58:235-41; 2002.

 2002 Hämta här
  15. Borelli F, Izzo AA, Ernst E.
Pharmacological Effects of Cimicifuga racemosa
Life Sci 73:1215-29; 2003.

 2003 Hämta här
  16. Briese V, Stammwitz U, Friede M, Henneicke-von Zepelin, HH:
Black cohosh with or without St. Johns wort for symptom-specific climacteric treatment - Results of a large-scale, controlled, observational study.
Maturitas 57: 405 - 414; 2007.

 2007 Hämta här
  17. Brücker A:
Beitrag zur Phytotherapie hormonaler Störungen der Frau.
Med Welt 44: 2331-33, 1960.

 1960  
  18. Bundesanzeiger: Monographie Cimicifugae racemosae rhizoma.
BAnz Jg 41, Seite 1070, Nr 43 vom 02.03.1989.

 1989  
  19. Burdette JE, Liu J, Chen SN, et al.:
Black Cohosh Acts as a Mixed Competitive Ligand and Partial Agonist of the
Serotonin Receptor.
J Agric Food Chem 51:5661–70; 2003.

 2003 Hämta här
  20. CIPS (eds.):
Internationale Skalen für die Psychiatrie.
Weinheim: Beltz Test GmbH, 1981, pp. 147–9.

1981  
  21. Daiber W:
Klimakterische Beschwerden: ohne Hormone zum Erfolg!
Ärztliche Praxis 35: 1946-1947, 1983.

 1983  
  22. Dayani N, McNaught R, Shenolikar S, Smith RG:
Receptor interconversion model of hormone action.
Biochemistry 29:2691-8, 1990.

 1990  
  23. Dixon-Shanies D, Shaikh N:
Growth inhibition of human breast cancer cells by herbs and phytoestrogens.
Oncology Reports 6: 1383–7, 1999.

 1999 Hämta här
  24. Dücker EM, Kopanski L, Jarry H, Wuttke W:
Effects of extracts from Cimicifuga racemosa on gonadotropin release in
menopausal women and ovariectomized rats.
Planta Med 57:420–4, 1991.

 1991  
  25. Eagon CL, Elm MS, Teepe AG, et al.
Oestrogenicity of medicinal botanicals in rat liver and other tissues.
Hepatology 26: 502A, 1997.

 1997  
 

26. Einbond LS, Shimizu M, Xiao D, et al.
Growth inhibitory activity of extracts and purified components of black cohosh
on human breast cancer cells.
Breast Cancer Research and Treatment 83: 221-31, 2004

2004
  
  27. Einer-Jensen N, Zhao J, Andersen KP, Kristoffersen K.
Cimicifuga and Melbrosia lack oestrogenic effests in mice and rats.
Maturitas 25:149-53, 1996.

 1996  
  28. Foster S:
Black Cohosh, Cimicifuga racemosa – A literature reciew.
HerbalGram 46:35-50; 1999

 1999  
  29. Freudenstein J, Bodinet C:
Influence of an isopropanolic aqueous extract of Cimicifugae Racemosae rhizoma
on the proliferation of MCF 7 cells.
Poster, 23. Int. LOF-Symposium: Phyto-Oestrogens, Gent, January 1999.

 1999 Hämta här
  30. Freudenstein J, Dasenbrock C, Nisslein T:
Lack of promotion of estrogen dependent mammary gland tumors in vivo by
an isopropanolic Black Cohosh extract.
Cancer Res 62(12):3448-52; 2002

 2002 Hämta här
  31. Földes J:
Die Wirkung eines Extraktes aus Cimicifuga racemosa.
Ärztl Forsch 13: 623 - 624, 1959.

 1959  
  32. Gambacciani M, Genazzani A R:
The study of a million women (and hopefully fewer mistakes).
Gynecol Endocrinol 17: 359-62, 2003.

 2003  
  33. Glade M:
Sixth Annual Congreee on Women’s Health, Washington, DC, June 21–24, 1998.
Nutrition 15: 334 – 5, 1999.

 1999
  
  34. Gonzales G, Carrillo C:
Blood serotonin levels in postmenopausal women: Effects of age and serum oestradiol levels.
Maturitas 17, 23-9; 1993.

1993  
  35. Grünewald J:
Standardized black cohosh (Cimicifuga) extract clinical monograph.
Quarterly Rev Nat Med Summer: 117-125; 1998

 1998  
  36. Görlich N:
Behandlung ovarieller Störungen in der Allgemeinenpraxis.
Ärztl Praxis 14: 1742 - 1743, 1962.

 1962  
  37. Hagels H, Baumert-Krauss J, Freudenstein J:
Composition of phenolic constituents in Cimicifuga racemosa.
Abstract P1B/03 in: Abstracts of International Congress and 48th Annual Meeting
of the Society for Medicinal Plant Research. Zürich, 3-7 September 2000.

 2000  
  38. Hagers Handbuch der Pharmazeutischen Praxis 2. Erg. Band.
Blaschek W, Hänsel R, Keller K, Reichling J, Rimpler H, Schneider G, Eds.
Springer Verlag, Berlin, 1998, pp. 374–81.

1998

 

  
  39. Harnischfeger G, Stolze H:
Notabene Medici 10: 446 - 450, 1980.

 1980  
  40. Hauser GA:
Häufigkeit klimakterischer Symptome – eine Literaturübersicht.
In: Menopause, Hormonsubstitution heute Bd 5.
Lauritzen C. (Hrsg.), Edition Informed, München, pp. 18 – 21, 1992.

 1992  
  41. Hauser GA, Huber IC, Keller PJ, Lauritzen C, Schneider HP
Menopause rating scale
Zentralbl Gynakol 116 (1): 16-23; 1994

 1994 Hämta här
  42. Hauser GA
Diagnosis and evaluation of climacteric symptoms. The "Menopause Rating Scale" MRS helps in diagnosis and evaluation of therapeutic effectiveness.
Fortschr Med 114 (5): 49-52; 1996

 1996 Hämta här
  43. Hegnauer R:
Chemotaxonomie der Pflanzen. Band 9:332, 1990.

 1990  
  44. Heizer H:
Kritisches zur Cimicifuga-Therapie bei Hormonalen Störungen der Frau.
Med Klinik 55: 232 - 233, 1960.

 1960
  
  45. Hemmi H, Kitame F, Ishida N, Kusamo G, Kondo G, Nozoe S:
J Pharm Dyn 2: 339 - 349, 1979.

 1979
  
  46. Henneicke-von Zepelin HH, Becher H, schröder-Bernhardi D, Stammwitz U.
Pharmacoepidemiologic Cohort Study on the Administration of Remifemin / Remifemin Plus in Patients with Breast Cancer, Including Hormone Receptor-Positive Tumors.
Annual Meeting of the German Menopause-Society on 17-18 June 2005 in Münster, Germany

 2005 Hämta här
  47. Henneicke-von Zepelin HH.
Isopropanolic black cohosh extract and recurrence-free survival after breast cancer.
Int J Clin Pharm Ther vol 45, no. 3, pp. 143-154, 2007.

2007 Hämta här
  48. Hernandez Munoz G, Pluchino S:
Cimicifuga racemosa for the treatment of hot flushes in women surviving breast cancer.
Maturitas 44, Suppl. 1, pp 59,65; 2003

 2003
  
  49. Holt S:
Natural approaches to promote sexual function.
Part 2: Stimulants and dietary supplements.
Alternative and Compl. Therapies, October 1999: 279 – 285.

1999
  
  50. Hulley S, Grady D, Bush T, et al.:
Randomized Trial of Estrogen plus Progestin for Secondary Prevention of
Coronary Heart Disease in Postmenopausal Women.
JAMA 280: 605 – 13, 1998.

 1998  
  51. Huntley A, Ernst E:
A systematic review of the saftey of black cohosh.
Menopause 10: 58-64, 2003

 2003  
       
  Gå till utskriftsvänlig sida här